FDA Brief

Warning letters Biologics

FDA warning letter to

CSL Behring

Issued Sep 9, 2025Posted Sep 16, 2025Center for Biologics Evaluation and Research (CBER)

Advertising & Promotional Labeling/Drugs/Biological Products. We haven't summarized this letter yet. Read it on fda.gov.